The combination therapy of rTMS and oxytocin may improve postpartum depression behavior by downregulating cell apoptosis, increasing synaptic plasticity, regulating the activity of microglia and astrocytes, and regulating autophagy. The gene discussed is OXT; the disease is postpartum depression.